Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.,Biology of Blood and Marrow Transplantation

当前位置： X-MOL 学术 › Biol. Blood Marrow Transplant. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.
Biology of Blood and Marrow Transplantation ( IF 5.609 ) Pub Date : 2019-04-17 , DOI: 10.1016/j.bbmt.2019.04.012
Mahmoud Aljurf ₁ , Daniel Weisdorf ₂ , Shahrukh Hashmi ₃ , Amr Nassar ₄ , Eliane Gluckman ₅ , Mohamad Mohty ₆ , Doug Rizzo ₇ , Marcelo Pasquini ₇ , Mehdi Hamadani ₇ , Wael Saber ₇ , Parameswaran Hari ₇ , Mohamed Kharfan-Dabaja ₈ , Navneet Majhail ₉ , Usama Gerges ₁₀ , Amir Ali Hamidieh ₁₁ , Fazal Hussain ₁ , Alaa Elhaddad ₄ , Hossam K Mahmoud ₄ , Abdelghani Tbakhi ₁₂ , Tarek Ben Othman ₁₃ , Rose-Marie Hamladji ₁₄ , Mohamed Amine Bekadja ₁₅ , Parvez Ahmed ₁₆ , Ali Bazarbachi ₁₇ , Salman Adil ₁₈ , Salman Alkindi ₁₉ , Saleh Ladeb ₁₃ , David Dennison ₁₉ , Moosa Patel ₂₀ , Peihua Lu ₂₁ , Asma El Quessar ₂₂ , Shinichiro Okamoto ₂₃ , Yoshiko Atsuta ₂₄ , Ayman Alhejazi ₂₅ , Mouhab F Ayas ₁ , Syed O Ahmed ₁ , Nickolas Novitzky ₂₆ , Alok Srivastava ₂₇ , Adriana Seber ₂₈ , Hassan El Solh ₁ , Ardeshir Ghavamzadeh ₁₁ , Dennis Confer ₇ , Yoshihisa Kodera ₂₉ , Greinix Hildegard ₃₀ , Jeff Szer ₃₁ , Mary M Horowitz ₇ , Dietger Niederwieser ₃₂

Affiliation

Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
University of Minnesota, Minneapolis, Minnesota.
Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Department of Medicine, Mayo Clinic, Rochester, Minnesota.
National Cancer Institute, Cairo University, Cairo, Egypt.
Eurocord Hôpital Saint-Louis and University Paris Diderot, Paris, France.
Hopital Saint-Antoine, Sorbonne University, Paris, France.
Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
Department of Medicine, Division of Hematology-Oncology and Blood and Marrow Transplantation program, Mayo Clinic, Jacksonville, Florida.
Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio.
Hematologic Malignancies & Bone Marrow Transplant, Department of Medicial Oncology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York.
Hematology, Oncology and SCT Research Center, Tehran University of Medical Sciences, Tehran, Iran.
King Hussein Cancer Center, Amman, Jordan.
Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
Pierre and Marie Curie Center, Algiers, Algeria.
University Hospital Establishment 1st Nov, Oran, Algeria.
Armed Forces Institute of Transplantation, Rawalpindi, Pakistan.
Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
Aga Khan University Hospital, Karachi, Pakistan.
Sultan Qaboos University Hospital, Muscat, Oman.
University of the Witwatersrand, Johannesburg, South Africa.
Hebei Yanda Ludaopei Hospital, Langfang, China.
Hôpital 20 Août, Casablanca, Morocco.
Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Keio University School of Medicine, Tokyo, Japan.
King Abdulaziz Medical City, NGHA, Riyadh, Saudi Arabia.
African Blood & Marrow Transplantation Society, South Africa.
Christian Medical College and Hospital, Bagayam, Vellore, India.
Instituto de Oncologia Pediatrica, Sao Paulo, Brazil.
Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan.
Medical University of Graz, Graz, Austria.
Department of Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia.
Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan; Department of Hematology and Medical Oncology, University Hospital, Leipzig, Germany.

The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. Although this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state-of-the-art treatments, including transplantation, by providing financial, technological, legal, ethical, and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population and potentially provide long-term cost savings by circumventing the need for their citizens to seek care abroad. The costs of establishing an HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. In addition, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT, and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation for establishing HSCT programs, with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in resource-constrained settings.

更新日期：2019-04-17

点击分享查看原文

点击收藏

公开下载

本刊介绍/投稿指南11